Phreesia, Inc. (PHR)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 11:41AM EDT. Market open.
| Previous close | 30.78 |
| Open | 31.18 |
| Bid | 30.71 x 1400 |
| Ask | 0.00 x 800 |
| Day's range | 30.61 - 31.51 |
| 52-week range | 13.19 - 40.00 |
| Volume | |
| Avg. volume | 414,030 |
| Market cap | 1.615B |
| Beta (5Y monthly) | 0.64 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.69 |
| Earnings date | 31 May 2023 - 05 June 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 38.71 |
- Business Wire
Unlimited Systems Partners with Phreesia, Improving Efficiency and Offering an Integrated Patient-Driven Intake Experience for Oncology Groups
CINCINNATI & WILMINGTON, Del., March 29, 2023--Unlimited Systems and Phreesia are offering a new integration for independent oncology practices and health systems.
- Simply Wall St.
Investors might be losing patience for Phreesia's (NYSE:PHR) increasing losses, as stock sheds 6.4% over the past week
Phreesia, Inc. ( NYSE:PHR ) shareholders have seen the share price descend 11% over the month. But that doesn't change...
- Zacks
Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates
Phreesia (PHR) delivered earnings and revenue surprises of 7.69% and 2.56%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
© 2023 Yahoo. All rights reserved.
